Clinical Trial

Biomarker for Premotor Parkinson's Disease

Study Description

Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease

This is a prospective observational study investigating the utility of 7 Tesla MRI to quantify nigrosome1 signal in a cohort of individuals with recent onset Parkinson's disease and in at-risk cohorts at a premotor state of Parkinson's disease.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

MRI

Additional Information

Official Study Title

Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease

Clinical Trial ID

NCT03288909

ParticipAid ID

YerDwb